Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial.

McMullan CJ, Lambers Heerspink HJ, Parving HH, Dwyer JP, Forman JP, de Zeeuw D
Am J Kidney Dis. 2014 64 (5): 714-22

PMID: 25064674 · DOI:10.1053/j.ajkd.2014.06.008

MeSH Terms (20)

Aged Angiotensin II Type 1 Receptor Blockers Biphenyl Compounds Blood Pressure Cardiovascular Diseases Cohort Studies Diabetes Mellitus, Type 2 Diabetic Nephropathies Double-Blind Method Female Follow-Up Studies Humans Irbesartan Kidney Male Middle Aged Office Visits Prospective Studies Tetrazoles Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: